Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Maze Therapeutics, Inc. - Common Stock (NQ:MAZE)

41.31 -0.79 (-1.86%)

Streaming Delayed Price Updated: 11:26 AM EST, Dec 29, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	167,866
Open	41.51
Bid (Size)	41.19 (200)
Ask (Size)	41.44 (200)
Prev. Close	42.10
Today's Range	40.00 - 41.51
52wk Range	6.710 - 43.29
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Foresite Capital Goes Bullish on Cytokinetics (CYTK), Snapping Up 458K Shares ↗

December 08, 2025

Foresite Capital Goes Bullish on Cytokinetics (CYTK), Snapping Up 458K Shares

Via The Motley Fool

Maze Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

November 06, 2025

From Maze Therapeutics, Inc.

Via GlobeNewswire

Performance

YTD	+159.0%	+159.0%
1 Month	+9.4%	+9.4%
3 Month	+63.9%	+63.9%
6 Month	+236.7%	+236.7%
1 Year	+159.0%	+159.0%

More News

Maze Therapeutics to Present Additional Data Highlighting the Advancement of MZE829 and MZE782 Programs at ASN Kidney Week

November 06, 2025

From Maze Therapeutics, Inc.

Via GlobeNewswire

Maze Therapeutics to Participate in Four Upcoming Investor Conferences

November 04, 2025

From Maze Therapeutics, Inc.

Via GlobeNewswire

Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors

October 06, 2025

From Maze Therapeutics, Inc.

Via GlobeNewswire

Biotech Breakouts: 3 Stocks With Massive Upside Potential ↗

September 17, 2025

Via MarketBeat

What's going on in today's session ↗

September 11, 2025

Via Chartmill

Maze Shares Jump As Investors Bet Big On Experimental Treatment's Potential ↗

September 11, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 11, 2025

Via Benzinga

Which stocks are moving on Thursday? ↗

September 11, 2025

Via Chartmill

Maze Therapeutics, Opendoor Technologies, Oxford Industries, VNET Group And Other Big Stocks Moving Higher On Thursday ↗

September 11, 2025

Via Benzinga

Thursday's session: gap up and gap down stocks ↗

September 11, 2025

Via Chartmill

Why Maze Therapeutics, Up 51%, Was Shocked By Its Own Test Results ↗

September 11, 2025

Via Investor's Business Daily

Discover the top movers in Thursday's pre-market session. ↗

September 11, 2025

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 11, 2025

Via Benzinga

Maze Therapeutics Announces Oversubscribed $150.0 Million Private Placement

September 11, 2025

From Maze Therapeutics, Inc.

Via GlobeNewswire

Maze Therapeutics Announces Positive First-in-Human Results from Phase 1 Trial of MZE782, Establishing Proof of Mechanism for a Potent, Oral SLC6A19 Inhibitor with Potential to Treat Phenylketonuria (PKU) and Chronic Kidney Disease (CKD)

September 11, 2025

From Maze Therapeutics, Inc.

Via GlobeNewswire

Maze Therapeutics Appoints Misbah Tahir as Chief Financial Officer

September 02, 2025

From Maze Therapeutics, Inc.

Via GlobeNewswire

Maze Therapeutics Inc (NASDAQ:MAZE) Reports Narrower Q2 2025 Loss, Extends Cash Runway to 2027 ↗

August 12, 2025

Via Chartmill

Maze Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights

August 12, 2025

From Maze Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 28, 2025

Via Benzinga

This Celsius Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

July 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 16, 2025

Via Benzinga

Maze Therapeutics to Participate in Two Upcoming Investor Conferences

July 10, 2025

From Maze Therapeutics, Inc.

Via GlobeNewswire

Maze Therapeutics to Participate in the Jefferies 2025 Global Healthcare Conference

May 29, 2025

From Maze Therapeutics, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Maze Therapeutics, Inc. - Common Stock publicly traded?

Yes, Maze Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Maze Therapeutics, Inc. - Common Stock trade on?

Maze Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Maze Therapeutics, Inc. - Common Stock?

The ticker symbol for Maze Therapeutics, Inc. - Common Stock is MAZE on the Nasdaq Stock Market

What is the current price of Maze Therapeutics, Inc. - Common Stock?

The current price of Maze Therapeutics, Inc. - Common Stock is 41.31

When was Maze Therapeutics, Inc. - Common Stock last traded?

The last trade of Maze Therapeutics, Inc. - Common Stock was at 12/29/25 11:26 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.